文献速递创伤骨科骨质疏松与代谢性骨病小儿骨科

阿司福酶α成功治疗低磷酸酯酶症青少年跖骨应力性骨折延迟愈合

Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia.
PubMed 文献 · Osteoporos Int · 2026-04-25

这是首例儿科低磷酸酯酶症患者中阿司福酶α支持延迟愈合应力性骨折愈合的病例报告,支持对标准保守治疗后骨折延迟愈合的儿科低磷酸酯酶症患者考虑启动阿司福酶α。

要点

  • 低磷酸酯酶症患者骨折可表现为延迟愈合甚至不愈合,儿科患者因高体力活动水平尤其受影响。
  • 骨折间隙骨密度增加36%,恢复至第五跖骨平均骨密度水平。

核心结论

  • 本文报告首例儿科低磷酸酯酶症患者中阿司福酶α支持延迟愈合应力性骨折愈合的病例。
  • 研究结果支持对标准保守治疗后骨折延迟愈合的儿科低磷酸酯酶症患者考虑启动阿司福酶α。

研究设计与样本

  • 病例报告:一例携带ALPL基因致病性变异的16岁女孩,第五跖骨基底部骨折17周后仍症状持续且影像学无愈合。

主要发现

  • 骨折间隙骨密度增加36%,恢复至第五跖骨平均骨密度水平。

关键数值与推荐

  • 阿司福酶α按体重给药,遵循已批准的儿科方案。
  • 骨折17周(4个月)后仍症状持续,MRI和CBCT无愈合征象。

临床怎么用

  • 对儿科低磷酸酯酶症患者标准保守治疗后骨折延迟愈合,可考虑启动阿司福酶α。

局限性

  • 本文为单例病例报告,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypophosphatasia (HPP) is a rare metabolic bone disorder that can present with a wide spectrum of skeletal and extraskeletal signs and symptoms. Biochemically, HPP is characterized by a decreased activity of the tissue nonspecific alkaline phosphatase (TNSALP) and subsequent accumulation of inorganic pyrophosphate (PPi). Fractures in patients with HPP can show delayed healing or even progress to nonunion. In pediatric patients, fractures can be particularly debilitating, as children usually engage in high levels of physical activity. CASE PRESENTATION: The 16-year-old girl, carrying a pathogenic variant in the ALPL gene, presented 17 weeks (4 months) after the initial diagnosis of a fracture at the base of the fifth metatarsal (MT-V). The patient was still symptomatic, and magnetic resonance imaging and cone beam computed tomography (CBCT) showed no radiological signs of healing despite immobilization. Given the prolonged absence of fracture consolidation, TNSALP enzyme replacement therapy with asfotase alfa (AA) was initiated and dosed according to body weight, in line with approved pediatric regimens. Thirteen weeks after initiation of AA, CBCT demonstrated full radiological consolidation. Furthermore, bone mineral density (BMD) in the fracture gap increased by 36%, returning to the average BMD level of the MT-V. CONCLUSION: Here we present, to the best of our knowledge, the first pediatric case in which treatment with AA supported healing of a delayed union stress fracture in the context of clinically diagnosed and genetically supported HPP. Our findings support considering AA initiation in pediatric patients diagnosed with HPP who present delayed fracture healing despite standard conservative management.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Windels O, Simon A, Muschol N, et al. Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia. Osteoporos Int. 2026. PMID: 42032047. doi:10.1007/s00198-026-08039-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。